Home › Lipoid Nephrosis › Florida
Lipoid Nephrosis clinical trials in Florida
4 studies for Lipoid Nephrosis are looking for participants at sites in Florida.
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- University Of South Florida - Parent- Site Number : 8400025, Tampa
RecruitingPhase 2
Ages 16 to 75 · All sexes · Updated Sep 23, 2026 · NCT06500702Study of WAL0921 in Patients With Glomerular Kidney Diseases
- D & H Tamarac Research Center, Tamarac
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT06466135Nephrotic Syndrome Study Network
- University of Miami Miller School of Medicine, Miami
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of Miami, Leonard M. Miller School of Medicine, Miami
- Nicklaus Children's Hospital, Miami
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.